5h
A Look At Turning Point Brands (TPB) Valuation As FDA Nicotine Pouch Delays Raise Growth Questions
Turning Point Brands (TPB) has been hit by a wave of regulatory headlines, as reports of the Food and Drug Administration slowing nicotine pouch approvals triggered a sharp selloff and raised fresh ...
New versions of both Zyn and Velo — both popular nicotine pouch brands — are still pending approval by the FDA ...
Analysts view a reported FDA delay as a negative for the tobacco giant.
FDA planned to fast-track applications for authorization, but agency reviewers raise alarm over addiction risk ...
Popular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track Food and Drug ...
The FDA’s selective relationship with its data isn’t just hypocritical; it affects policy at the federal and state levels.
By Emma Rumney and Patrick Wingrove LONDON/NEW YORK, April 1 (Reuters) - Popular nicotine pouch products have yet to be ...
When granting licenses, the FDA weighs whether products can help smokers switch to a less harmful form of nicotine while not ...
This proposed tax in New York would sharply raise the cost of a nicotine product that is far less hazardous than cigarettes, ...
Popular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track Food and Drug ...
4dOpinion
New York's Governor Seems Indifferent to the Health Consequences of a Steep Tax on Nicotine Pouches
The Hochul administration also argues that a hefty tax will deter teenagers from using nicotine pouches. But according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results